Euda Health Holdings Stock Market Value
| EUDA Stock | 1.31 0.01 0.77% |
| Symbol | EUDA |
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. Projected growth potential of EUDA fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive EUDA Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding EUDA Health Holdings requires distinguishing between market price and book value, where the latter reflects EUDA's accounting equity. The concept of intrinsic value—what EUDA Health's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push EUDA Health's price substantially above or below its fundamental value.
It's important to distinguish between EUDA Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EUDA Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EUDA Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
EUDA Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to EUDA Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of EUDA Health.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in EUDA Health on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding EUDA Health Holdings or generate 0.0% return on investment in EUDA Health over 90 days. EUDA Health is related to or competes with American Well, Hyperfine, ZEN Graphene, Quince Therapeutics, Fonar, Precision BioSciences, and Fractyl Health. More
EUDA Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure EUDA Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess EUDA Health Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 12.28 | |||
| Information Ratio | 0.0032 | |||
| Maximum Drawdown | 83.79 | |||
| Value At Risk | (11.55) | |||
| Potential Upside | 13.58 |
EUDA Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for EUDA Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as EUDA Health's standard deviation. In reality, there are many statistical measures that can use EUDA Health historical prices to predict the future EUDA Health's volatility.| Risk Adjusted Performance | 0.0152 | |||
| Jensen Alpha | 0.0468 | |||
| Total Risk Alpha | (0.82) | |||
| Sortino Ratio | 0.0033 | |||
| Treynor Ratio | 0.104 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of EUDA Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
EUDA Health January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0152 | |||
| Market Risk Adjusted Performance | 0.114 | |||
| Mean Deviation | 7.67 | |||
| Semi Deviation | 11.5 | |||
| Downside Deviation | 12.28 | |||
| Coefficient Of Variation | 12625.87 | |||
| Standard Deviation | 12.93 | |||
| Variance | 167.19 | |||
| Information Ratio | 0.0032 | |||
| Jensen Alpha | 0.0468 | |||
| Total Risk Alpha | (0.82) | |||
| Sortino Ratio | 0.0033 | |||
| Treynor Ratio | 0.104 | |||
| Maximum Drawdown | 83.79 | |||
| Value At Risk | (11.55) | |||
| Potential Upside | 13.58 | |||
| Downside Variance | 150.68 | |||
| Semi Variance | 132.31 | |||
| Expected Short fall | (8.76) | |||
| Skewness | 0.3011 | |||
| Kurtosis | 6.92 |
EUDA Health Holdings Backtested Returns
At this point, EUDA Health is out of control. EUDA Health Holdings secures Sharpe Ratio (or Efficiency) of close to zero, which denotes the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for EUDA Health Holdings, which you can use to evaluate the volatility of the firm. Please confirm EUDA Health's Downside Deviation of 12.28, coefficient of variation of 12625.87, and Mean Deviation of 7.67 to check if the risk estimate we provide is consistent with the expected return of 0.1%. The firm shows a Beta (market volatility) of 0.89, which means possible diversification benefits within a given portfolio. EUDA Health returns are very sensitive to returns on the market. As the market goes up or down, EUDA Health is expected to follow. EUDA Health Holdings now shows a risk of 12.93%. Please confirm EUDA Health Holdings jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to decide if EUDA Health Holdings will be following its price patterns.
Auto-correlation | 0.31 |
Below average predictability
EUDA Health Holdings has below average predictability. Overlapping area represents the amount of predictability between EUDA Health time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of EUDA Health Holdings price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current EUDA Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.2 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Check out EUDA Health Correlation, EUDA Health Volatility and EUDA Health Performance module to complement your research on EUDA Health. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
EUDA Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.